Overview

Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function. The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.
Phase:
N/A
Details
Lead Sponsor:
Assaf-Harofeh Medical Center
Treatments:
Acetylcysteine
N-monoacetylcystine
Criteria
Inclusion Criteria:

- Patients with ESRD, treated with chronic hemodialysis

Exclusion Criteria:

- Patients will be excluded from the study if they are:

1. Patients with acute renal failure

2. Currently treated with antioxidants ( NAC, vitamin E ets.)